ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß<sub>2</sub> adrenoceptor agonist (MABA) radiolabelled at both functional moieties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß₂ adrenoceptor agonist (MABA) radiolabelled at both functional moieties

Published:2023-04-03 Issue:4 Volume:53 Page:288-308
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Ghiglieri Alberto¹,Messina Monica¹,Cenacchi Valentina²,Piutti Claudia¹,Cinato Flavio¹,Brogin Giandomenico²,Puccini Paola²

Affiliation:

1. Accelera Srl, Nerviano, Milano, Italy

2. Chiesi Farmaceutici SpA, Parma, Italy

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2023.2230490

Reference33 articles.

1. Factors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease

2. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

3. Mass Balance Studies, with a Focus on Anticancer Drugs

4. Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β₂ Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases

5. Novel long-acting bronchodilators for COPD and asthma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update;Expert Opinion on Pharmacotherapy;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP